Delivered-To: ouchendans62@gmail.com
Received: by 2002:ac0:fa0b:0:b0:2da:d504:b4a4 with SMTP id g11csp929036ims;
        Wed, 31 May 2023 09:05:04 -0700 (PDT)
X-Google-Smtp-Source: ACHHUZ6mP66mPMM+My6m0vowhb2pUnb/++7GpphoSMLj8BqrjJBuOyqGz/Y4C6Q40Vz7Yqf+01Ac
X-Received: by 2002:a05:6870:5b0f:b0:19f:367d:b90a with SMTP id ds15-20020a0568705b0f00b0019f367db90amr3321396oab.7.1685549103751;
        Wed, 31 May 2023 09:05:03 -0700 (PDT)
ARC-Seal: i=1; a=rsa-sha256; t=1685549103; cv=none;
        d=google.com; s=arc-20160816;
        b=o2n5eMpPjLPfWHs7I+NQQTgRBE1xyjdSwZp7SBUcrRVOs7Z65wp3e4WGOG18IoyBPo
         ZBEoXM9NmpVOkskwY+lnLmFHhjl7J4ILDsgLE9VbPcEJEKS/z13BZx6f/fdNW3BDlsd/
         danzGc6lhzWsfiPtiKanD5Ywz/m9WLNCyPK/OaPPYnFk7jPLZP7TuF8KQiucK9FAS09N
         4N48ANXKgWIzJ664xwooAVzbY12mcZ1uEcQOyb4T6MKe1aVvxpffb7Km/9uWagcNiGfr
         66RM9da0eC7M2bqqUagnZmAX2Kx9yX8uuEVr2lMHPKI7dKCzzCTMiYBQRl5OIzBnJNhl
         ZhTw==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=feedback-id:message-id:list-id:reply-to:mime-version
         :list-unsubscribe-post:list-unsubscribe:date:subject:to:from
         :dkim-signature;
        bh=prBHcaTupoZATqvEC/ngpGWOsQMGkEwmeqBRVX9DTPw=;
        b=UHvjfnnu4wo/nIvyCcYnolTtr6UwoMvf2apRAk9iLvAl0pr03FadefjPNxUkFkwcKS
         sEoYWS1Q637oYQqvvHz/i/qVGODh/u3tIWKlOXST4XAGX7R7i0EhrOqBTTzHxqo9Um3k
         EpkjfRtC06CyB2DRaPxfgOU7QkIYcHPvjT+QTFnO43IwVADwMZpCWxLzRAoi+J8VwtwZ
         mwz+8hW0gxB+LU7gBt/NBPn+9yh3cmsBHlUwNvWxtchrS5iekHOn7syI1u8f3ivEtp7j
         +r1eq3ZjQMEwGGF9Jgvfy1+f+jHPJQN4GTUp8UPJMTFhmsJXzY8xa0rM+PHE1fl5dtjK
         EGbQ==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@email.politico.com header.s=200608 header.b="YQ4lP/MV";
       spf=pass (google.com: domain of bounce-630319_html-1405096349-9802631-1376319-0@bounce.politicoemail.com designates 68.232.198.10 as permitted sender) smtp.mailfrom=bounce-630319_HTML-1405096349-9802631-1376319-0@bounce.politicoemail.com;
       dmarc=pass (p=QUARANTINE sp=QUARANTINE dis=NONE) header.from=email.politico.com
Return-Path: <bounce-630319_HTML-1405096349-9802631-1376319-0@bounce.politicoemail.com>
Received: from mta.politicoemail.com (mta.politicoemail.com. [68.232.198.10])
        by mx.google.com with ESMTPS id b16-20020a4a98d0000000b005563f828e61si8101670ooj.15.2023.05.31.09.05.03
        for <ouchendans62@gmail.com>
        (version=TLS1_2 cipher=ECDHE-ECDSA-AES128-GCM-SHA256 bits=128/128);
        Wed, 31 May 2023 09:05:03 -0700 (PDT)
Received-SPF: pass (google.com: domain of bounce-630319_html-1405096349-9802631-1376319-0@bounce.politicoemail.com designates 68.232.198.10 as permitted sender) client-ip=68.232.198.10;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@email.politico.com header.s=200608 header.b="YQ4lP/MV";
       spf=pass (google.com: domain of bounce-630319_html-1405096349-9802631-1376319-0@bounce.politicoemail.com designates 68.232.198.10 as permitted sender) smtp.mailfrom=bounce-630319_HTML-1405096349-9802631-1376319-0@bounce.politicoemail.com;
       dmarc=pass (p=QUARANTINE sp=QUARANTINE dis=NONE) header.from=email.politico.com
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; s=200608; d=email.politico.com;
 h=From:To:Subject:Date:List-Unsubscribe:List-Unsubscribe-Post:MIME-Version:
 Reply-To:List-ID:X-CSA-Complaints:Message-ID:Content-Type;
 i=prescriptionpulse@email.politico.com;
 bh=prBHcaTupoZATqvEC/ngpGWOsQMGkEwmeqBRVX9DTPw=;
 b=YQ4lP/MVQzWOCTUEK+3KFGQhEibeKXNFAmqt/1IKi7yIetM0M0JX0ZzqmwXPpRF9QZvkbSxQnOD2
   OPievx40qbAiKd+jDLc9LVqGV5cnszaRMdt9z18Wfh8e9FsbRIeiXd1B2FKv1pHZAvimzXpOGGuP
   y0tKTdF46iDBGWv3Pgo=
Received: by mta.politicoemail.com id heto2u2fmd4k for <ouchendans62@gmail.com>; Wed, 31 May 2023 16:02:10 +0000 (envelope-from <bounce-630319_HTML-1405096349-9802631-1376319-0@bounce.politicoemail.com>)
From: "POLITICO's Prescription Pulse" <prescriptionpulse@email.politico.com>
To: <ouchendans62@gmail.com>
Subject: A debt-ceiling win for pharma
Date: Wed, 31 May 2023 10:02:10 -0600
List-Unsubscribe: <https://click.politicoemail.com/subscription_center.aspx?jwt=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJtaWQiOiIxMzc2MzE5IiwicyI6IjE0MDUwOTYzNDkiLCJsaWQiOiI2MzAzMTkiLCJqIjoiOTgwMjYzMSIsImpiIjoiMCIsImQiOiI0MDEyNiJ9.cQQAt1HD8hHT8vVxgu41pJifkj2Cm0UpGo9jMwaVgjY>, <mailto:leave-fcb51273756705741a4c342838-fdf61574756104747317747c-fe921d787566027e74-fe9115737262077c7c-ffcf14@leave.politicoemail.com>
List-Unsubscribe-Post: List-Unsubscribe=One-Click
x-CSA-Compliance-Source: SFMC
MIME-Version: 1.0
Reply-To: "POLITICO, LLC" <reply-fe921d787566027e74-630319_HTML-1405096349-1376319-0@politicoemail.com>
List-ID: <1376319.xt.local>
X-CSA-Complaints: csa-complaints@eco.de
X-SFMC-Stack: 4
x-job: 1376319_9802631
Message-ID: <7ef0db73-8d3b-433d-973b-fe01f4fd3da0@las1s04mta952.xt.local>
Feedback-ID: 1376319:9802631:68.232.198.10:sfmktgcld
Content-Type: multipart/alternative;
	boundary="jD9FmTgHBcVw=_?:"

This is a multi-part message in MIME format.

--jD9FmTgHBcVw=_?:
Content-Type: text/plain;
	charset="utf-8"
Content-Transfer-Encoding: 8bit

Presented by Express Scripts by Evernorth: Delivered every Tuesday and Friday by 12 p.m., Prescription Pulse examines the latest pharmaceutical news and policy. May 31, 2023 View in browser  
By Katherine Ellen Foley and David Lim

Presented by

With Annie Snider

 Driving the day


The pharma industry likes what it sees in the debt ceiling bill, a draft of which is pictured above. | Jon Elswick/AP Photo

DRUGMAKERS CAUTIOUSLY OPTIMISTIC ABOUT DEAL — The pharmaceutical industry expressed relief Tuesday over the debt ceiling deal struck by the White House and House Speaker Kevin McCarthy. A big part of their relief is the deal retaining $5 billion for the funding of research into improved Covid-19 vaccines and treatments.

Covid vaccine maker Novavax said it “remains encouraged by the continued investment in and recognition of the need for continued development of Covid vaccines.”

The debt limit package, if signed into law, would claw back about $30 billion in federal funding appropriated during the pandemic. It doesn’t touch the Inflation Reduction Act’s drug price negotiation provisions despite the Biden administration's push to expand them in its fiscal 2024 budget proposal.

“Given the impacts on capital markets and capital formation, we have been watching closely — cautiously, optimistically — as negotiations have progressed,” Nick Shipley, Biotechnology Innovation Organization’s chief advocacy officer, said.

A list specifying the clawed-back Covid relief funds was obtained by POLITICO from a White House source granted anonymity to share some of the details of the debt ceiling package. The list, which the administration is sharing with lawmakers, outlines the exclusions from the clawbacks. They include more than $800 million to monitor and strengthen pharmaceutical supply chains and roughly $2 billion for CDC activities such as genomic surveillance of the virus.

But public health experts await more details. Georges Benjamin, executive director of the American Public Health Association, praised the agreement for maintaining funding for vaccines and treatments for people without health insurance and veterans, and ongoing research for better vaccines and treatments. But if a Covid surge hits the U.S. in the future, another emergency appropriation might be necessary, he added.

“It is a problem, but probably low-risk for now,” Benjamin said.

The Association of State and Territorial Health Officials and other public health groups are still trying to understand the impact of the Covid-funding clawbacks on the CDC and state public health efforts to strengthen public health infrastructure.

“It looks like a lot of [the infrastructure] is still in place, but we are not certain of that,” ASTHO chief medical officer Marcus Plescia said.

IT'S WEDNESDAY. WELCOME TO PRESCRIPTION PULSE. Our warmest welcome to the National Zoo and Conservation Biology Institute’s newest baby gorilla, who was born over the holiday weekend.

Send news, tips and summer weather to David Lim (dlim@politico.com or @davidalim) or Katherine Ellen Foley (kfoley@politico.com or @katherineefoley).

TODAY ON OUR PULSE CHECK PODCAST, host Ben Leonard chats with POLITICO's Victoria Guida about her data analysis revealing how low-income workers saw significant wage gains during the pandemic as a result of market changes and several government policies. Plus: What the data shows about health care workers.


Listen to today’s Pulse Check podcast
     
A message from Express Scripts by Evernorth:

60 million Americans live in rural areas. Yet less than 10 percent of physicians practice in those parts of the country. That’s half the number of physicians needed to provide essential care to those communities. Express Scripts by Evernorth is expanding health care access for rural communities by advocating for more pharmacy services and reimbursement opportunities. Making health care more accessible for all. Learn more.
     Industry Intel


The FDA is expected to approve Pfizer's RSV vaccine for older adults today. | Andrew Burton/Getty Images

DECISION DAY FOR SECOND RSV VACCINE — The FDA will likely approve Wednesday a respiratory syncytial virus vaccine for older adults from Pfizer. It’s not a certainty, but if approved, the vaccine would be the second RSV shot available to adults over 60, who are susceptible to severe disease caused by the virus. The FDA approved the first RSV vaccine for older adults from GSK earlier this month.

An endorsement with caveats: The agency’s independent advisory committee gave a lukewarm recommendation in February that the FDA approve Pfizer’s RSV vaccine. The panel voted 7-4 with one abstention that the data the company provided showed the vaccine candidate was effective and 7-4 with one abstention that it was safe.

A late-stage clinical trial showed the candidate was more than 85 percent effective at preventing moderate cases of RSV, though it followed participants for just one season. Pfizer is studying the vaccine’s durability through multiple RSV seasons, and no data is yet available. Three study participants out of 17,215 who received the shot in the completed trial developed severe autoimmune reactions affecting their nervous system, sparking concerns about its safety.

However, the agency’s advisers narrowly voted in favor of the potential benefit of an RSV vaccine outweighing its potential risks.

POSITIVE RESULTS FOR A BLOOD DISORDER TREATMENT — Pfizer said on Tuesday that Phase III trial results of its weekly subcutaneous injection intended to treat hemophilia significantly reduced the number of bleeding episodes patients experienced compared to existing treatment. Currently, people living with hemophilia, which puts them at risk for severe bleeding, must receive frequent and medically supervised infusions.

The company said it plans to present data from the trial at upcoming conferences and will file an application for FDA approval in the coming months.




POLITICO’s Health Care Summit on Wednesday, June 7, will explore how tech and innovation are transforming health care and the challenges ahead for access and delivery in the U.S. Register now.


 MEDICAL DEVICES
NEW ETHYLENE OXIDE DEADLINE — Under the terms of a settlement agreement detailed in the Federal Register on Tuesday with environmental groups, EPA said it will finalize by March 1 stringent new rules governing emissions of the potential carcinogenic gas from medical sterilization facilities.

That puts in place a hard deadline for finalizing a hot-button rule proposed this spring that has raised concerns by federal health regulators and the medical device industry about potential disruptions to the supply chain for everything from catheters to artificial heart valves, Annie reports.

The EPA had targeted October for finalizing the rule. The settlement agreement will be open for public comment on June 30 and then must be approved by a federal judge.

  
GET READY FOR GLOBAL TECH DAY: Join POLITICO Live as we launch our first Global Tech Day alongside London Tech Week on Thursday, June 15. Register now for continuing updates and to be a part of this momentous and program-packed day! From the blockchain, to AI, and autonomous vehicles, technology is changing how power is exercised around the world, so who will write the rules? REGISTER HERE.
     Pharma Worldwide
NO CONSENSUS ON HEALTH AGREEMENT YET — Participating countries at the World Health Assembly in Geneva failed to adopt the Health for Peace Initiative on Tuesday, POLITICO’s Ashleigh Furlong reports.

The initiative seeks to ensure that global health emergency responses don’t trigger conflicts, but of the 194 nations, some, including Brazil, India and South Africa, said they had concerns the initiative encroaches on state sovereignty. They opted to potentially revisit the proposal at the 2024 World Health Assembly meeting.

     
A message from Express Scripts by Evernorth:


     Document Drawer
The FDA proposed a rule on Tuesday that would create a prescription drug guide for consumers called “Patient Medication Information.” The one-page, standardized documents would provide patients with clear, accessible information intended to help them take their drug products properly.

The FDA published final guidance on Friday on how drug companies should adjust for the differences in characteristics, such as race, ethnicity or socioeconomic status, of participants in their analyses of randomized clinical trials.

The White House Office of Management and Budget is reviewing a proposed rule from CMS that will float potential options for cutting reimbursement rates for 340B hospitals. The proposal is a response to the Supreme Court's June 2022 ruling against HHS in American Hospital Association v. Becerra, which held cuts instituted in 2018 were unlawful.

  
DON’T MISS POLITICO’S HEALTH CARE SUMMIT: The Covid-19 pandemic helped spur innovation in health care, from the wide adoption of telemedicine, health apps and online pharmacies to mRNA vaccines. But what will the next health care innovations look like? Join POLITICO on Wednesday June 7 for our Health Care Summit to explore how tech and innovation are transforming care and the challenges ahead for access and delivery in the United States. REGISTER NOW.
     Quick Hits
Alabama’s abortion ban, one of the most restrictive in the nation, is threatening the financial operations of the state’s clinics that provide comprehensive women’s health services, Alice Miranda Ollstein reports for POLITICO magazine.

For STAT+, Lizzy Lawrence reports on how Stimwave gave thousands of patients a fraudulent device to treat their chronic pain.

Elizabeth Holmes, founder of the once high-flying but now defunct Theranos blood diagnostics firm, reported to a Texas federal minimum-security women’s prison Tuesday to begin her sentence of 11 years and three months for defrauding the company’s investors, Erin Griffith reports for The New York Times.

     
A message from Express Scripts by Evernorth:

Express Scripts by Evernorth believes America’s rural communities, and independent pharmacies, deserve better. That’s why we’re leading the way with new ways to close gaps in care through partnerships with independent pharmacies across the U.S.


 We’re establishing the industry’s first Independent Pharmacy Advisory Committee to help pharmacies everywhere better support underserved communities. We’re making it easier to offer much-needed services like vaccinations, lifestyle counseling, and behavioral health screenings. And we’re increasing reimbursements paid to rural pharmacies for the essential services they provide today and well into the future.


 We invite all our partners and our competitors to follow our lead. And help improve the quality of care for all. Learn more.
      
Follow us on Twitter

David Lim @davidalim

Lauren Gardner @Gardner_LM

Katherine Ellen Foley @katherineefoley
  
Follow us
  
To change your alert settings, please log in at https://go.politicoemail.com/?qs=9c8ae169f1c00b30c2d6b92bfeacb240391bd6f94d5a8dc15949ae7afe293a6c8154df49b7659da0ad9c9f982914ad5ae75a6291f6ecf40a  https://click.politicoemail.com/profile_center.aspx?qs=9c775bb5bc5419bcb2e8309a5c29d12d93e82fe774a453a2c88ac91522ee0de6b9552e4a7140a0deeaed8441312db1116a45cebf32b390b1c52d78c1c5defd5c19413fd07bc37b07

This email was sent to ouchendans62@gmail.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

 Please click here and follow the steps to unsubscribe.
  

--jD9FmTgHBcVw=_?:
Content-Type: text/html;
	charset="utf-8"
Content-Transfer-Encoding: 8bit

<html><body><head>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
    <title></title>
    <!--[if gte mso 9]>
    <xml>
        <o:OfficeDocumentSettings>
            <o:AllowPNG/>
            <o:PixelsPerInch>96</o:PixelsPerInch>
        </o:OfficeDocumentSettings>
    </xml><![endif]-->
</head><!-- Everything above this line is "new" to the template. We'll have to experiment a bit to see if it causes troubles. --><!-- preview text --><div style="display:none;font-size:1px;color:#ffffff;line-height:1px;max-height:0px;max-width:0px;opacity:0;overflow:hidden;">    Presented by Express Scripts by Evernorth: Delivered every Tuesday and Friday by 12 p.m., Prescription Pulse examines the latest pharmaceutical news and policy.</div><table border="0" cellpadding="0" cellspacing="0" width="100%" bgcolor="#ffffff" style="padding:5px 0 15px 0;margin:0;text-align:center" role="presentation">    <tbody>    <tr>        <td>
<!-- Note: This is left blank to aid in centering across email clients --></td>        <td align="center" width="540">            <table width="100%" border="0" cellpadding="0" cellspacing="0" style="max-width:540px;table-layout:fixed;" role="presentation">                <tbody>                <!-- top date and utility link -->                <tr>    <td align="center">        <table width="100%" border="0" cellpadding="0" cellspacing="0" style="padding-bottom:15px;" role="presentation">            <tbody>            <tr>                <td width="50%" style="text-align:left;font-size:11px;font-family:Helvetica,sans-serif;color:#B1B4BD;margin:0;">May 31, 2023</td>                
<td width="50%" style="text-align:right;font-size:11px;font-family:Helvetica,sans-serif;color:#B1B4BD;margin:0;"><a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b303cbe4ee3946fb4b5b81b74869da55d18fb916bc514cb0a8b4d547d7b8d55360ff476193665b7b8f656681f6a91aa8845" target="_blank" style="color:#007BC7;text-decoration:none;">View in browser</a
></td>            </tr>            </tbody>        </table>    </td></tr>                <!-- divider line -->                <tr>    <td height="20" style="height:20px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td></tr>                <!-- logo and byline -->                <tr>    <td align="center" style="text-align:center;padding:0 20px 15px 20px;margin:0">                                    
<img src="https://static.politico.com/08/a8/4ffad4a6441aae6305940c688255/politico-prescription-pulse.png" title="2020_NewsletterLogo_Free_PrescriptionPulse" alt="POLITICO's Prescription Pulse newsletter logo" border="0" width="500" style="width:100%;max-width:500px;">                        </td></tr><tr>    <td align="center" style="padding:0 20px 10px 20px;">        <p style="text-align:center;font-family:Helvetica,sans-serif;font-size:11px;letter-spacing:2px;color:#B1B4BD;text-transform:uppercase;margin:0;">            By  <a
 href="mailto:kfoley@politico.com" target="_blank" style="color:#000000;text-decoration:none;font-weight:bold;">Katherine Ellen Foley</a
> and  <a
 href="mailto:dlim@politico.com" target="_blank" style="color:#000000;text-decoration:none;font-weight:bold;">David Lim</a
>        </p>    </td></tr>                <!-- sponsor logo -->                    <tr>        <td style="padding-bottom:15px; min-width:100%; width:100%;">            <table width="100%" cellpadding="0" cellspacing="0" border="0" style="background-color:#FFFFFF; min-width:100%;" role="presentation">                <tbody>                                        <tr>                        <td align="center" style="min-width:100%; width: 100%;">                            <table cellspacing="0" cellpadding="0" border="0">                                <tbody><tr>                                    <td width="50%" valign="middle" style="text-align:right;padding-right:6px;">
<p style="font-family:Helvetica,sans-serif;font-size:12px;color:#6E7381;margin:0;">Presented by</p></td>                                    <td width="50%" valign="middle" style="text-align:left;">                                        <div style="width:100%;max-width:100px;">                                                                                            
<img width="100" src="https://www.politico.com/dims4/default/fa846fe/2147483647/resize/200x/quality/90/?url=https%3A%2F%2Fstatic.politico.com%2Ffc%2F3d%2F48f53c924a8781bd22b23d5eb3b6%2Fes-logo-blue-500x500.jpeg" alt="Express Scripts by Evernorth" border="0" style="width:100px;max-width:100%;">                                                                                    </div>                                    </td>                                </tr>                            </tbody></table>                        </td>                    </tr>                                    </tbody>            </table>        </td>    </tr>                
<!-- body -->                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><i
>With Annie Snider</i
><br></p></td>                    </tr>                                    <tr>                        <td style="padding-bottom:10px; min-width:100%; width:100%;"><!-- Inline styling used, as its an email content --><table width="100%" cellpadding="0" cellspacing="0" border="0" role="presentation" style="background-color:#121522; min-width:100%;">    <tbody>    <tr>        <td style="text-align:left;font-family:Helvetica,sans-serif;font-size:12px;color:#FFFFFF;text-transform:uppercase;font-weight:bold;letter-spacing:2px;padding-top:10px;padding-bottom:10px;padding-left:20px;margin:0;" valign="middle">Driving the day</td>    </tr>    </tbody></table></td>                    
</tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"><p align="center" style="margin:0 0 20px 0;">
<img src="https://www.politico.com/dims4/default/1b3a092/2147483647/resize/1000x/quality/90/?url=https%3A%2F%2Fstatic.politico.com%2F13%2Fb8%2F4880b0cd40b38b25e19274420432%2Fdebt-limit-00645.jpg" title="20230531-debtceilingbill-AP" alt="The draft of the debt ceiling bill is pictured." width="500" style="width:100%;max-width:500px;"></p><p style="font-family:Helvetica,sans-serif;font-size:12px;color:#6E7381;margin-bottom:24px;">The pharma industry likes what it sees in the debt ceiling bill, a draft of which is pictured above.  |  Jon Elswick/AP Photo</p></td>                    </tr>                                    <tr>                        
<td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><span style="color:#b70000;font-weight:bold;font-family:sans-serif;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">DRUGMAKERS CAUTIOUSLY OPTIMISTIC ABOUT DEAL</strong
></span> &#8212; The pharmaceutical industry expressed relief Tuesday over the debt ceiling deal struck by the White House and House Speaker <span>Kevin McCarthy</span>. A big part of their relief is the deal retaining $5 billion for the funding of research into improved Covid-19 vaccines and treatments.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">Covid vaccine maker Novavax said it &#8220;remains encouraged by the continued investment in and recognition of the need for continued development of Covid vaccines.&#8221;</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">The <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b307ee580548d70c3fd09920f9f8ba418d3a3a558f9239ee79443e1f2eadd9ea59ce81fb409b60ae134071b9a42076ac547" target="_blank">debt limit package</a
>, if signed into law, would claw back about $30 billion in federal funding appropriated during the pandemic. It doesn&#8217;t touch the <span>Inflation Reduction Act</span>&#8217;s drug price negotiation provisions despite the Biden administration's push to expand them in its fiscal 2024 budget proposal.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">&#8220;Given the impacts on capital markets and capital formation, we have been watching closely &#8212; cautiously, optimistically &#8212; as negotiations have progressed,&#8221; Nick Shipley, Biotechnology Innovation Organization&#8217;s chief advocacy officer, said.</p>
<p style="margin-top:0;margin-bottom:24px;line-height:24px;">A <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b301ae025240cf253b97027c23d8ac03496522155cc30070c804a18f9ecd2db0b61e5f963c1de63a81ffaa0f090c1d8b26e" target="_blank">list specifying the clawed-back Covid relief funds</a
> was obtained by POLITICO from a White House source granted anonymity to share some of the details of the debt ceiling package. The list, which the administration is sharing with lawmakers, outlines the exclusions from the clawbacks. They include more than $800 million to monitor and strengthen pharmaceutical supply chains and roughly $2 billion for CDC activities such as genomic surveillance of the virus.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">But public health experts await more details. </strong
>Georges Benjamin, executive director of the American Public Health Association, praised the agreement for maintaining funding for vaccines and treatments for people without health insurance and veterans, and ongoing research for better vaccines and treatments. But if a Covid surge hits the U.S. in the future, another emergency appropriation might be necessary, he added.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">&#8220;It is a problem, but probably low-risk for now,&#8221; Benjamin said.</p>
<p style="margin-top:0;margin-bottom:24px;line-height:24px;">The Association of State and Territorial Health Officials and other public health groups are still trying to understand the impact of the Covid-funding clawbacks on the CDC and state public health efforts to strengthen public health infrastructure.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">&#8220;It looks like a lot of [the infrastructure] is still in place, but we are not certain of that,&#8221; ASTHO chief medical officer Marcus Plescia said.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><span style="color:#b70000;font-weight:bold;font-family:sans-serif;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">IT'S WEDNESDAY. WELCOME TO PRESCRIPTION PULSE.</strong
></span> Our warmest welcome to the National Zoo and Conservation Biology Institute&#8217;s newest baby gorilla, who was born <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b301ae73e5baf989d12d1d5a5f7d4adfa402df828ddb38e03a911bb8d3ffb3d033c1a235865beb9f7a00894c07f88c83f37" target="_blank">over the holiday weekend</a
>.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">Send news, tips and summer weather to David Lim (<a
 href="mailto:dlim@politico.com" target="_blank">dlim@politico.com</a
> or <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b300067dee0bfbc9e87fe8789bb33c71a1bdaab33f4969e2cdc3a15da413ac1b65e84612a6b981b6efbfb0b4582434ae84e" target="_blank">@davidalim</a
>) or Katherine Ellen Foley (<a
 href="mailto:kfoley@politico.com" target="_blank">kfoley@politico.com</a
> or <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30769e82a375adecfe5812bff65df4b8bdc30db73cd4815616c110138d656f7cb95a811310cd5a9821b1c4057a65b39762" target="_blank">@katherineefoley</a
>).</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><span style="color:#b70000;font-weight:bold;font-family:sans-serif;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">TODAY ON OUR</strong
></span> <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b3059c008896d6e857de5b701f24508ad4146eb99478aca340f3526859c1da1a8770ac44ad3617b6d493bb1826844f0a313" target="_blank"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">PULSE CHECK PODCAST</strong
></a
><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">,&nbsp;</strong
>host Ben Leonard chats with POLITICO's Victoria Guida about her data analysis revealing how low-income workers saw significant wage gains during the pandemic as a result of market changes and several government policies. Plus: What the data shows about health care workers.<br></p></td>                    </tr>                                    <tr>                        <td style="padding-bottom:24px;">    <table width="100%" cellpadding="0" cellspacing="10" border="0" role="presentation" style="border-top:1px solid #E5E7EB;border-bottom:1px solid #E5E7EB;border-collapse: separate;">        <tbody>        <tr>            <td valign="top" style="width:40px;text-align:right;"><a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30decf95a1cb6636181c495a285426df33b277b806e5b5604eeed3176bc9b4b18b131616107de124873703a84bacf6a40f" target="_blank"><img src="https://static.politico.com/hosted/icon-headphones-red%402x.png" title="Play audio" alt="Play audio" width="30" border="0"></a
></td>            <td valign="middle" style="text-align:left;">                <p style="margin:0;font-family:Helvetica,sans-serif;font-size:16px;color:#000000;"><a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30decf95a1cb6636181c495a285426df33b277b806e5b5604eeed3176bc9b4b18b131616107de124873703a84bacf6a40f" target="_blank" style="color:#000000;text-decoration:none;font-weight:bold;">Listen to today&#8217;s Pulse Check podcast</a
></p></td>        </tr>        </tbody>    </table></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                    <tr>                            </tr><tr>    <td height="15" style="height:15px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td>    </tr>    <tr>    <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;background-color:#ffffff;">                                            <p style="font-family:Helvetica,sans-serif;font-size:12px;margin-top:0;margin-bottom:10px;color:#000000;">A message from Express Scripts by Evernorth:</p>                                                
<p style="margin-top:0;margin-bottom:20px;line-height:24px;color:#000000;">60 million Americans live in rural areas. Yet less than&#8239;10 percent of physicians&#8239;practice in those parts of the country. That&#8217;s half the number of physicians needed to provide essential care to those communities. Express Scripts by Evernorth is expanding health care access for rural communities by advocating for more pharmacy services and reimbursement opportunities. Making health care more accessible for all. <a
 href="https://go.politicoemail.com/?qs=f935585c930b311045fe103ee4ca6ebbfad4025f597ac21efdd9a87841a217fad2c8f5456d1f00d8a5bf1bd04f4e361bd1e2ed0491c270b6" target="_blank" style="text-decoration:underline;color:#007bc7;">Learn more.</a
></p>                                            </td></tr>    <tr>        <td height="20" style="height:20px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td>    </tr>                                                        <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                    <tr>                        <td style="padding-bottom:10px; min-width:100%; width:100%;"><!-- Inline styling used, as its an email content --><table width="100%" cellpadding="0" cellspacing="0" border="0" role="presentation" style="background-color:#121522; min-width:100%;">    <tbody>    <tr>        
<td style="text-align:left;font-family:Helvetica,sans-serif;font-size:12px;color:#FFFFFF;text-transform:uppercase;font-weight:bold;letter-spacing:2px;padding-top:10px;padding-bottom:10px;padding-left:20px;margin:0;" valign="middle">Industry Intel</td>    </tr>    </tbody></table></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;">
<p align="center" style="margin:0 0 20px 0;"><img src="https://www.politico.com/dims4/default/813c7c8/2147483647/resize/1000x/quality/90/?url=https%3A%2F%2Fstatic.politico.com%2Fd2%2Fcb%2F7459539343f69b823c08b2d13785%2Fgettyimages-470821380.jpg" title="20181116_Pfizer sign_Getty_900" alt="The Pfizer logo." width="500" style="width:100%;max-width:500px;"></p><p style="font-family:Helvetica,sans-serif;font-size:12px;color:#6E7381;margin-bottom:24px;">The FDA is expected to approve Pfizer's RSV vaccine for older adults today.  |  Andrew Burton/Getty Images</p></td>                    </tr>                                    <tr>                        
<td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><span style="color:#b70000;font-weight:bold;font-family:sans-serif;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">DECISION DAY FOR SECOND RSV VACCINE</strong
></span> &#8212; The FDA will likely approve Wednesday a respiratory syncytial virus vaccine for older adults from Pfizer. It&#8217;s not a certainty, but if approved, the vaccine would be the second RSV shot available to adults over 60, who are susceptible to severe disease caused by the virus. The FDA approved the first RSV vaccine for older adults from GSK <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30978ab4bfebc105891d9edc9929eebaee54cce62c66b9b2ba9b41ecef6eb52cc6b7c0640e0f9bcff1d0ace0cb7bdfb6d7" target="_blank">earlier this month</a
>.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">An endorsement with caveats: </strong
>The agency&#8217;s independent advisory committee gave a lukewarm recommendation in February that the FDA approve Pfizer&#8217;s RSV vaccine. The panel voted 7-4 with one abstention that the data the company provided showed the vaccine candidate was effective and 7-4 with one abstention that it was safe.</p>
<p style="margin-top:0;margin-bottom:24px;line-height:24px;">A late-stage clinical trial showed the candidate was more than 85 percent effective at preventing moderate cases of RSV, though it followed participants for just one season. Pfizer is studying the vaccine&#8217;s durability through multiple RSV seasons, and no data is yet available. Three study participants out of 17,215 who received the shot in the completed trial developed severe autoimmune reactions affecting their nervous system, sparking concerns about its safety.</p>
<p style="margin-top:0;margin-bottom:24px;line-height:24px;">However, the agency&#8217;s advisers narrowly voted in favor of the potential benefit of an RSV vaccine outweighing its potential risks.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><span style="color:#b70000;font-weight:bold;font-family:sans-serif;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">POSITIVE RESULTS FOR A BLOOD DISORDER TREATMENT</strong
></span> &#8212; Pfizer said on Tuesday that Phase III trial results of its weekly subcutaneous injection intended to treat hemophilia significantly reduced the number of bleeding episodes patients experienced compared to existing treatment. Currently, people living with hemophilia, which puts them at risk for severe bleeding, must receive frequent and medically supervised infusions.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">The company said it plans to present data from the trial at upcoming conferences and will file an application for FDA approval in the coming months.<br></p></td>                    </tr>                                    
<tr>                        </tr><tr>    <td style="padding:0 20px 20px 20px;">        <table cellspacing="0" cellpadding="0" border="0" width="100%" style="background-color:#282D40;">            <tbody>            <tr>                <td align="center" style="padding:20px;color:#FFFFFF;">                    <p style="font-family:Helvetica,sans-serif;font-size:40px;color:#FFFFFF;text-align:center;line-height:34px;margin-top:0;margin-bottom:10px;"></p>                    <p style="font-family:Helvetica,sans-serif;font-size:16px;color:#FFFFFF;text-align:center;margin-top:0;margin-bottom:0px;line-height:24px;"><b
><i
>POLITICO&#8217;s Health Care Summit</i
></b
><i
>&nbsp;on Wednesday, June 7, will explore how tech and innovation are transforming health care and the challenges ahead for access and delivery in the U.S.&nbsp;</i
><a
 style="color:#1DA1F2;text-decoration:none;" href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30e93bc337c428753e77dfcb66ad93419f1e62e34d4f434f6130764b44840dfd7a3e1baa8f16904aad0416535edfb7d6d3"><i
>Register now</i
></a
><i
>.</i
></p>                    <p style="font-family:Helvetica,sans-serif;font-size:14px;color:#FFFFFF;text-align:center;margin-top:0;margin-bottom:0px;line-height:24px;text-transform:uppercase;font-weight:bold;"></p>                </td>            </tr>            </tbody>        </table>    </td></tr>                                                        <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                    <tr>                        <td style="padding-bottom:10px; min-width:100%; width:100%;"><!-- Inline styling used, as its an email content -->
<table width="100%" cellpadding="0" cellspacing="0" border="0" role="presentation" style="background-color:#121522; min-width:100%;">    <tbody>    <tr>        <td style="text-align:left;font-family:Helvetica,sans-serif;font-size:12px;color:#FFFFFF;text-transform:uppercase;font-weight:bold;letter-spacing:2px;padding-top:10px;padding-bottom:10px;padding-left:20px;margin:0;" valign="middle">MEDICAL DEVICES</td>    </tr>    </tbody></table></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;">
<p style="margin-top:0;margin-bottom:24px;line-height:24px;"><span style="color:#b70000;font-weight:bold;font-family:sans-serif;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">NEW ETHYLENE OXIDE DEADLINE</strong
></span> &#8212; Under the <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30cea75a61a79fa1e310937384f6a1b0b78a7d57a0c7cc33855f4907d3729659934fcdde4d8687f6f8577d43f70c15fd9d" target="_blank">terms of a settlement agreement</a
> detailed in the Federal Register on Tuesday with <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30884e2a19e9e1abe1ac98fabc7db3defc10735595aefc99d251f9e72f94453d4627c15887a341e92403eccd9482113e97" target="_blank">environmental groups,</a
> EPA said it will finalize by March 1 stringent new rules governing emissions of the potential carcinogenic gas from medical sterilization facilities.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">That puts in place a hard deadline for finalizing </strong
>a <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30d5ecd7bd67e20645ebba30804031803e6371af88291dbc81dc4362e06b8bf43551544577e5128b0a2a5e817dff1e40c8" target="_blank">hot-button rule proposed this spring</a
> that has raised concerns by federal health regulators and the medical device industry about potential disruptions to the supply chain for everything from catheters to artificial heart valves, Annie reports.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">The EPA had targeted October for finalizing the rule. The settlement agreement will be open for public comment on June 30 and then must be approved by a federal judge.<br></p></td>                    </tr>                                    <tr>                        </tr><tr>    <td height="10" style="height:10px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td></tr><tr>    
<td style="padding:20px 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;background-color:#FFFFFF;">                                    <p style="margin-top:0;margin-bottom:20px;line-height:24px;margin-bottom:20px;color:#000000;">                <strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">GET READY FOR GLOBAL TECH DAY: </strong
>Join POLITICO Live as we launch our first Global Tech Day alongside London Tech Week on Thursday, June 15. Register now for continuing updates and to be a part of this momentous and program-packed day! From the blockchain, to AI, and autonomous vehicles, technology is changing how power is exercised around the world, so who will write the rules? <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30a0986ea617d593707f916e0869e00ca22b18899f9648f1414d85c6e6544a1f7a291a859ca30aca16da647d8c7568e3b9" target="_blank" style="text-decoration:underline;color:#007BC7;">REGISTER HERE</a
>.            </p>            </td></tr><tr>    <td height="10" style="height:10px; font-size:0; border-bottom:1px solid #E5E7EB;">&nbsp;</td></tr><tr>    <td height="15" style="height:15px; font-size:0;">&nbsp;</td></tr>                                                        <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                    <tr>                        <td style="padding-bottom:10px; min-width:100%; width:100%;"><!-- Inline styling used, as its an email content -->
<table width="100%" cellpadding="0" cellspacing="0" border="0" role="presentation" style="background-color:#121522; min-width:100%;">    <tbody>    <tr>        <td style="text-align:left;font-family:Helvetica,sans-serif;font-size:12px;color:#FFFFFF;text-transform:uppercase;font-weight:bold;letter-spacing:2px;padding-top:10px;padding-bottom:10px;padding-left:20px;margin:0;" valign="middle">Pharma Worldwide</td>    </tr>    </tbody></table></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;">
<p style="margin-top:0;margin-bottom:24px;line-height:24px;"><span style="color:#b70000;font-weight:bold;font-family:sans-serif;"><strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">NO CONSENSUS ON HEALTH AGREEMENT YET</strong
></span> &#8212; Participating countries at the World Health Assembly in Geneva <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b303d0f785ef1c61bebb48dd0ba6eb765bd82dc995ca2446d47a8afb56be5fc653e47cc6b34a9ac40730f8afb140ecf846c" target="_blank">failed to adopt the Health for Peace Initiative on Tuesday</a
>, POLITICO&#8217;s Ashleigh Furlong reports.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">The initiative seeks to ensure that global health emergency responses don&#8217;t trigger conflicts, but of the 194 nations, some, including Brazil, India and South Africa, said they had concerns the initiative encroaches on state sovereignty. They opted to potentially revisit the proposal at the 2024 World Health Assembly meeting.<br></p></td>                    </tr>                                    <tr>                            </tr><tr>    <td height="15" style="height:15px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td>    </tr>    <tr>    
<td style="padding:0 20px 0 20px;text-align:center;font-family:Georgia,serif;font-size:16px;color:#000000;background-color:#FFFFFF;">                                            <p style="font-family:Helvetica,sans-serif;font-size:12px;margin-top:0;margin-bottom:10px;color:#000000;">A message from Express Scripts by Evernorth:</p>                                                        <p style="margin-top:0;margin-bottom:15px;line-height:15px;">                                            <a
 href="https://go.politicoemail.com/?qs=f935585c930b31104784ea9b7958f5d0e83239c6671a9f1ffce784286a27fc4aef26eb2109b642114c80d2892c4f14e3fbdafdd2abd6d68b" target="_blank"><img src="https://www.politico.com/dims4/default/639eac4/2147483647/resize/600x/quality/90/?url=https%3A%2F%2Fstatic.politico.com%2Fbf%2Fce%2Fb0fef4a949b9b9fa2c376fa1f4c0%2Feng-na-ip-ruralcare-accessible-300x250-static.jpg" title="Advertisement Image" alt="Advertisement Image" border="0" width="300" style="width:100%;max-width:300px;"></a
>                                        <img src="https://ad.doubleclick.net/ddm/ad/N7384.146504POLITICO0/B29926417.367482155;sz=1x1;ord=[timestamp]" border="0" a>                </p>                                                                                    </td></tr>    <tr>        <td height="20" style="height:20px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td>    </tr>                                                        <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                    <tr>                        <td style="padding-bottom:10px; min-width:100%; width:100%;"><!-- Inline styling used, as its an email content --><table width="100%" cellpadding="0" cellspacing="0" border="0" role="presentation" style="background-color:#121522; min-width:100%;">    <tbody>    <tr>        
<td style="text-align:left;font-family:Helvetica,sans-serif;font-size:12px;color:#FFFFFF;text-transform:uppercase;font-weight:bold;letter-spacing:2px;padding-top:10px;padding-bottom:10px;padding-left:20px;margin:0;" valign="middle">Document Drawer</td>    </tr>    </tbody></table></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"><p style="margin-top:0;margin-bottom:24px;line-height:24px;">The FDA <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b301da8aeb014441197dc74538145c06f87c6ae475e1ec10eb4078b966a7c65f1cd327352e61ad247a9911172ff3114cb9a" target="_blank">proposed a rule</a
> on Tuesday that would create a prescription drug guide for consumers called &#8220;Patient Medication Information.&#8221; The one-page, standardized documents would provide patients with clear, accessible information intended to help them take their drug products properly.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">The FDA <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b3011b10ccf56b0327e1a136680196fcbfcb98b88631f17c02ff6838321d23feae065e48ba0f3c997cf623e12a7f1297f93" target="_blank">published final guidance</a
> on Friday on how drug companies should adjust for the differences in characteristics, such as race, ethnicity or socioeconomic status, of participants in their analyses of randomized clinical trials.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">The White House Office of Management and Budget is <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b304ad2fcb5762f0e877413d41d5723b29eddf95964062dbf1594dd143be6b07dcc9009be8896996aa5fd8894fd6f71d5af" target="_blank">reviewing a proposed rule from CMS</a
> that will float potential options for cutting reimbursement rates for 340B hospitals. The proposal is a response to the Supreme Court's June 2022 ruling against HHS in <i
>American Hospital Association v. Becerra,</i
> which held cuts instituted in 2018 were unlawful.<br></p></td>                    </tr>                                    <tr>                        </tr><tr>    <td height="10" style="height:10px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td></tr><tr>    <td style="padding:20px 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;background-color:#FFFFFF;">                                    <p style="margin-top:0;margin-bottom:20px;line-height:24px;margin-bottom:20px;color:#000000;">                <strong
 style="font-family:Helvetica,sans-serif;font-weight:bold;">DON&#8217;T MISS POLITICO&#8217;S HEALTH CARE SUMMIT</strong
>: The Covid-19 pandemic helped spur innovation in health care, from the wide adoption of telemedicine, health apps and online pharmacies to mRNA vaccines. But what will the next health care innovations look like? Join POLITICO on Wednesday June 7 for our Health Care Summit to explore how tech and innovation are transforming care and the challenges ahead for access and delivery in the United States. <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b301b866620087fa34a986757139d556943057976e7b7d150e98b7172c15b87196ae922772f23a427671a0b281debbdb76d" style="text-decoration:underline;color:#007BC7;">REGISTER NOW</a
>.            </p>            </td></tr><tr>    <td height="10" style="height:10px; font-size:0; border-bottom:1px solid #E5E7EB;">&nbsp;</td></tr><tr>    <td height="15" style="height:15px; font-size:0;">&nbsp;</td></tr>                                                        <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                    <tr>                        <td style="padding-bottom:10px; min-width:100%; width:100%;"><!-- Inline styling used, as its an email content -->
<table width="100%" cellpadding="0" cellspacing="0" border="0" role="presentation" style="background-color:#121522; min-width:100%;">    <tbody>    <tr>        <td style="text-align:left;font-family:Helvetica,sans-serif;font-size:12px;color:#FFFFFF;text-transform:uppercase;font-weight:bold;letter-spacing:2px;padding-top:10px;padding-bottom:10px;padding-left:20px;margin:0;" valign="middle">Quick Hits</td>    </tr>    </tbody></table></td>                    </tr>                                    <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;">
<p style="margin-top:0;margin-bottom:24px;line-height:24px;">Alabama&#8217;s abortion ban, one of the most restrictive in the nation, <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b300690121ce06fe2d2060e037796f7ac789295dad99d011d0f1bb878e8ff879e103b4ec464aeda6a5968582544caecd666" target="_blank">is threatening the financial operations</a
> of the state&#8217;s clinics that provide comprehensive women&#8217;s health services, Alice Miranda Ollstein reports for POLITICO magazine.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">For STAT+, Lizzy Lawrence reports on how Stimwave <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b302b69ef5f316ab3bd0749ef4cb3f94e592fd73871b3edfe1bbb44ee8abc53c83502f17df0702270472a3464aea95b9b4e" target="_blank">gave thousands of patients a fraudulent device</a
> to treat their chronic pain.</p><p style="margin-top:0;margin-bottom:24px;line-height:24px;">Elizabeth Holmes, founder of the once high-flying but now defunct Theranos blood diagnostics firm, reported to a Texas federal <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b303f170ad06204c0f5e843eec72c47062a121634d84a4877ef74843e0fc0bdd64472cbd510de5597a092deb978649d33ba" target="_blank">minimum-security women&#8217;s prison</a
> Tuesday to begin her sentence of 11 years and three months for defrauding the company&#8217;s investors, Erin Griffith reports for The New York Times.<br></p></td>                    </tr>                                    <tr>                            </tr><tr>    <td height="15" style="height:15px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td>    </tr>    <tr>    <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;background-color:#ffffff;">                                            <p style="font-family:Helvetica,sans-serif;font-size:12px;margin-top:0;margin-bottom:10px;color:#000000;">A message from Express Scripts by Evernorth:</p>                                                
<p style="margin-top:0;margin-bottom:20px;line-height:24px;color:#000000;">Express Scripts by Evernorth believes America&#8217;s rural communities, and independent pharmacies, deserve better. That&#8217;s why we&#8217;re leading the way with new ways to close gaps in care through partnerships with independent pharmacies across the U.S.<br>
<br>We&#8217;re establishing the industry&#8217;s first Independent Pharmacy Advisory Committee to help pharmacies everywhere better support underserved communities. We&#8217;re making it easier to offer much-needed services like vaccinations, lifestyle counseling, and behavioral health screenings. And we&#8217;re increasing reimbursements paid to rural pharmacies for the essential services they provide today and well into the future.<br><br>We invite all our partners and our competitors to follow our lead. And help improve the quality of care for all. <a
 href="https://go.politicoemail.com/?qs=f935585c930b3110fb74ec4ca35b2730ee9d49215eb0d42439cd6f6dad7791b66b924b1ebaa1e5d5f94ade802d1ba91425c31e2d35c3d2ea" target="_blank" style="text-decoration:underline;color:#007bc7;">Learn more.</a
></p>                                            </td></tr>    <tr>        <td height="20" style="height:20px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td>    </tr>                                                        <tr>                        <td style="padding:0 20px 0 20px;text-align:left;font-family:Georgia,serif;font-size:16px;color:#000000;"></td>                    </tr>                                <!-- End Ad Copy -->                <tr>                                    </tr>                <!-- Post Body Content -->                <tr>                                    </tr>                <tr>                    <td height="20" style="height:20px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;
</td>                </tr>                <!-- Twitter Handles -->                                    <tr>    <td style="color:#000000;padding:0px 20px 20px 20px;text-align:left;">        <p style="font-family:Helvetica,sans-serif;font-size:20px;color:#000000;margin-top:0;margin-bottom:15px;"><strong
>Follow us on Twitter</strong
></p>        <table cellpadding="0" cellspacing="0" border="0" role="presentation">            <tbody>            <tr>                <td width="52" valign="middle" style="text-align:left;padding-right:10px;"><img src="https://static.politico.com/hosted/icon-twitter-circle-blue%402x.png" title="" alt="" width="50" style="max-width:50px;"></td>                <td valign="middle" style="text-align:left;font-family:Helvetica,sans-serif;font-size:14px;font-weight:bold;color:#000000;">                                            <p style="margin-top:0;margin-bottom:5px;line-height:14px;">David Lim <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30399469f91cbea4494a399ca3c81f63337b5c27e815e06ff04829ecf6400aea181afa736d78fef9e92675322b7d00c019" style="color:#007BC7;text-decoration:none;font-weight:bold;" target="_blank">@davidalim</a
></p>                                            <p style="margin-top:0;margin-bottom:5px;line-height:14px;">Lauren Gardner <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30706d3377b948bd9206d0a3dc117c47fad0409eb2322465513cf39866d6527c4d6e0e6e19b27dc0fa97e1614eaf7d1f14" style="color:#007BC7;text-decoration:none;font-weight:bold;" target="_blank">@Gardner_LM</a
></p>                                            <p style="margin-top:0;margin-bottom:5px;line-height:14px;">Katherine Ellen Foley <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30769e82a375adecfe5812bff65df4b8bdc30db73cd4815616c110138d656f7cb95a811310cd5a9821b1c4057a65b39762" style="color:#007BC7;text-decoration:none;font-weight:bold;" target="_blank">@katherineefoley</a
></p>                                    </td>            </tr>            </tbody>        </table>    </td></tr><tr>    <td height="20" style="height:20px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td></tr>                                <!-- Family of Playbook -->                                <!-- Follow us -->                <tr>    <td style="color:#000000;padding:0px 20px 20px 20px;text-align:left;">        <p style="font-family:Helvetica,sans-serif;font-size:12px;color:#000000;margin-bottom:10px;line-height:14px;text-transform:uppercase;font-weight:bold;letter-spacing:2px;">Follow us</p>        
<table cellpadding="0" cellspacing="0" border="0" role="presentation">            <tbody>            <tr>                <td width="40" style="text-align:left;"><a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30f01c2525fb291b8f67c2e8a064275917581f6924e76f0f8c8e49cbae0a41bce166a194508b8de53eef5e46a072b14cfe" target="_blank"><img src="https://static.politico.com/hosted/icon-follow-facebook-gray%402x.png" title="Follow us on Facebook" alt="Follow us on Facebook" width="24" border="0" style="max-width:24px;"></a
></td>                <td width="40" style="text-align:left;"><a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30724c7f957f32133c468ac033b60bdd10578a2487af97e4fa048ffba9750101955fe63a8685fad5b3d3c87132b3ef8cf6" target="_blank"><img src="https://static.politico.com/hosted/icon-follow-twitter-gray%402x.png" title="Follow us on Twitter" alt="Follow us on Twitter" width="24" border="0" style="max-width:24px;"></a
></td>                <td width="40" style="text-align:left;"><a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30b148a60c4c6559fde6faae2016439be5f0ff32c37e1218a3465b606f09969d6a06a5a32c69fa252a9b4f2eea3361d792" target="_blank"><img src="https://static.politico.com/hosted/icon-follow-instagram-gray%402x.png" title="Follow us on Instagram" alt="Follow us on Instagram" width="24" border="0" style="max-width:24px;"></a
></td>                <td width="40" style="text-align:left;"><a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b3057d7c698db644223dee06016c190ef1edf8d548c563a1e72ffe468025c3656c671892eb07760fb9831d61e5960ebe186" target="_blank"><img src="https://static.politico.com/hosted/icon-follow-applePodcast-gray%402x.png" title="Listen on Apple Podcast" alt="Listen on Apple Podcast" width="24" border="0" style="max-width:24px;"></a
></td>            </tr>            </tbody>        </table>    </td></tr><tr>    <td height="20" style="height:20px; font-size:0; border-top:1px solid #E5E7EB;">&nbsp;</td></tr>                </tbody>            </table>        </td>        <td><!-- Note: This is left blank to aid in centering across email clients --></td>    </tr>    </tbody></table><!-- Everything below this line is "new" to the template. We'll have to experiment a bit to see if it causes troubles. --><!-- howler#email.footers/core-newsletter.footer.html -->
<table border="0" cellpadding="0" cellspacing="0" width="100%" bgcolor="#ffffff"
       style="padding:5px 0 15px 0;margin:0;text-align:center" role="presentation">
    <tbody>
    <tr>
        <td><!-- Note: This is left blank to aid in centering across email clients --></td>
        <td align="center" width="540">
            <table width="100%" border="0" cellpadding="0" cellspacing="0" style="max-width:540px" role="presentation">
                <tbody>
                <tr>
                    <td align="center" style="font-family:Helvetica,sans-serif;font-size:14px;color:#000000;">
                        <p style="margin-bottom:15px;line-height:24px;">To change your alert settings, please log in at
                            <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30c2d6b92bfeacb240391bd6f94d5a8dc15949ae7afe293a6c8154df49b7659da0ad9c9f982914ad5ae75a6291f6ecf40a" target="_blank" style="color:#007BC7;text-decoration:none;">https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings</a
>
                            <!--Commenting out the following line because it causes an undesired line to be displayed on outlook (some versions) and we couldn't find the use case of it-->
                            <!-- <span style="display:none;"><a
 href="https://click.politicoemail.com/profile_center.aspx?qs=9c775bb5bc5419bcb2e8309a5c29d12d93e82fe774a453a2c88ac91522ee0de6b9552e4a7140a0dec660378a38a16679">https://click.politicoemail.com/profile_center.aspx?qs=9c775bb5bc5419bcb2e8309a5c29d12d93e82fe774a453a2c88ac91522ee0de6b9552e4a7140a0dec660378a38a16679</a
></span> -->
                        </p>
                    </td>
                </tr>
                <tr>
                    <td align="center" style="padding-bottom:15px;"><img
                            src="https://static.politico.com/hosted/icon-politico-logo.png"
                            class="CToWUd"></td>
                </tr>
                <tr>
                    <td align="center"><p
                            style="font-family:Helvetica,sans-serif;font-size:14px;color:#000000;margin-bottom:15px;line-height:20px;">
                        This email was sent to ouchendans62@gmail.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA
                        <p style="font-family:Helvetica,sans-serif;font-size:14px;color:#000000;margin-bottom:15px;line-height:24px;">
                            

                            Please click <a
 href="https://go.politicoemail.com/?qs=9c8ae169f1c00b30fd3273c2586deabdfa2992cfe40210b36b256e18847dd607e25e8769b4bec94358af17b9eb2c62ab47622fa0d97e3da3" target="_blank" style="color:#007BC7;text-decoration:none;">here</a
> and follow the steps to unsubscribe.
                        </p>
                    </td>
                </tr>
                </tbody>
            </table>
        </td>
        <td><!-- Note: This is left blank to aid in centering across email clients --></td>
    </tr>
    </tbody>
</table>
<img src="https://click.politicoemail.com/open.aspx?ffcb10-fe921d787566027e74-fdea13797160037e701c7073-fe9115737262077c7c-fec9127375670574-fdf61574756104747317747c-ffcf14&d=40126&bmt=0" width="1" height="1" alt="">
</body></html><p email-meta style="display: none;opacity:0;">source=GoggleDocument, article=00000188-71e7-d63f-ab9a-f9f71dbb0000</p>

--jD9FmTgHBcVw=_?:--

